Stuart Ingall-Tombs
Analyst
Yes. So thanks, Simona, apologies. You asked a number of questions there about costs, what does that mean for 2025 synergies. So I'll try and sort of respond in the round, I think. So first thing, we haven't given guidance on 2025. We don't -- we never have at this time of the year given the North America performance we've seen, it certainly wouldn't be prudent to start now. But there are a number of moving pieces, and I'll try to give some color on that. Firstly, of course, we've got the organic growth trajectory, the impact of the integration, both positive and negative. So once we're through the other side, we'd expect growth to improve, but as we've said many times, as we're going through an integration, we get a short-term disruption. So key concern, of course, is the lower route density we're experiencing due to our volume decline and its impact on gross margins and through the integration where customer churn can be slightly elevated. Clearly, that's a concern, too. So we've got a few moving parts there. You referenced synergies. Look, so what did we say previously? We've said $65 million we gave that guidance at the prelims. But then at the interims, we said that of the additional $25 million marketing investment, marketing and customer care investment. In the second half, $10 million of that would flow through into 2025. So you've got a net there of $55 million is where we stand. I'm not really in a position right now to say quite what that looks like in 2025 because, of course, the point of the 2- to 3-month review is to determine what that future trajectory might look like. But there's the sort of the polls around which you can [ have that ] but clearly, there's an impact as we will be delaying. And most of those 2025 synergies are operational synergies so Q4 was always going to be higher than Q1. So it's a Q4 that you lose rather than a relatively low modest Q1. And then, yes, the review of the cost base, we've said we're finding about $22 million of cost reductions through FTE, the 250 heads that we've already done and about $10 million, we think, over Q4 and into 2025 should flow back. So of that GBP 50 million overrun, we've identified about $33 million that will come back the other way. But there's other items moving around as well. I've already referenced the density point from organic growth. There's other moving pieces. We've got small acquisitions, relative growth rate of the product business, which obviously impacts margin and rebuild of bonus provisions and those sorts of things as well. So quite a lot of moving pieces there. Not really ready to give guidance on 2025, but hopefully, there's enough information there that you've got some points around which you can think.